1. Gould H. J., III, Casey, G. P. & Paul, D. Painful diabetic neuropathy: Current perspective on development and management from bench to bedside – a review, in Analgesics: New Research (N. Gotsirize-Columbus, ed) 39-74 (Nova, Hauppauge, 2012).
2. Leslie T. K., Brückner, L., Chawla, S. & Brackenbury W. J. Inhibitory Effect of Eslicarbazepine Acetate and S-Licarbazepine on Nav1.5 Channels. Front. Pharmacol. 11, 555047 (2020). doi: 10.3389/fphar.2020.555047.
3. Gould H. J., III, Norleans, J., Ward T. D., Reid C. & Paul D. Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps. Oncotarget 9, 15606-15615 (2018). doi: 10.18632/oncotarget. 24581.
4. Paul D. et al. Targeted Osmotic Lysis of Highly Invasive Breast Carcinomas Using Pulsed Magnetic Field Stimulation of Voltage-Gated Sodium Channels and Pharmacological Blockade of Sodium Pumps. Cancers (Basel). 12, 1420 (2020). doi: 10.3390/cancers12061420.
5. Sahin-Erdemli I Medford, R. M. & Songu-Mize E. Regulation of Na+,K+-ATPase alpha-subunit isoforms in rat tissues during hypertension. Eur. J. Pharmacol. 292, 163-71 (1995). doi: 10.1016/0926-6917(95)90009-8.
6. Kaplan, D. I., Isom, L. L. & Petrou, S. Role of Sodium Channels in Epilepsy. Cold Spring Harb. Perspec.t Med. 6, a022814 (2016). doi: 10.1101/cshperspect.a022814.
7. Dib-Hajj, S. D. et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 128(Pt 8), 1847-1854. (2005)doi: 10.1093/brain/awh514.
8. Cox J. J. et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444, 894-8 (2006). doi: 10.1038/nature05413.
9. Goldberg Y. P. et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin. Genet.. 71, 311-9. (2007). doi: 10.1111/j.1399-0004.2007.00790.x..
10. Rush A.M., Cummins, T.R., Waxman S.G. Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J. Physiol. 579, 1-14 (2007). doi: 10.1113/jphysiol.2006.121483.
11. Djamgoz MBA, Fraser SP & Brackenbury WJ. In Vivo Evidence for Voltage-Gated Sodium Channel Expression in Carcinomas and Potentiation of Metastasis. Cancers (Basel). 11, 1675 (2019). doi: 10.3390/cancers11111675. PubMed PMID: 31661908.
12. Lopez-Charcas O, et al. Pharmacological and nutritional targeting of voltage-gated sodium channels in the treatment of cancers. iScience 24, 2021102270. doi: 10.1016/j.isci.2021.102270.
13. Capatina A.L., Lagos D. & Brackenbury, W.J. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges. Rev Physiol Biochem Pharmacol. (Springer Nature Switzerland AG) pp. 1-43 (2020). doi: 10.1007/112_2020_46.
14. Bueno-Orovio A. et al. Na/K pump regulation of cardiac repolarization: insights from a systems biology approach. Pflugers Arch. 466, 183-93 (2014). doi: 10.1007/s00424-013-1293-1.
15. Rao, V. R. Perez-Neut, M., Kaja, S. & Gentile, S. Voltage-gated ion channels in cancer cell proliferation. Cancers (Basel). 7, 849-875 (2015). doi: 10.3390/cancers7020813.
16. Blackiston, D. J., McLaughlin, K. A. & Levin, M. Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 8, 3527-3536 (2009). DOI: 10.4161/cc.8.21.9888.
17. Rosendo-Pineda, M. J., Moreno, C. M. & Vaca, L. Role of ion channels during cell division. Cell Calcium 91, 102258 (2020). doi: 10.1016/j.ceca.2020.102258.
18. MacFarlane, S.N. & Sondheimer, H. Changes in ion channel expression accompany cell cycle progression of spinal cord astrocytes. Glia 30, 39-48 (2000). DOI: 10.1002/(sici)1098-1136(200003)30:1<39::aid-glia5>3.0.co;2-s .
19. Coombs, J.L., Villaz, M. & Moody, W. J. Changes in voltage-dependent ion currents during meiosis and first mitosis in eggs of an ascidian. Dev. Biol.153, 272-282 (1992). doi: 10.1016/0012-1606(92)90112-t.
20. House C. D. et al. Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling. Sci. Rep. 5, 11541 (2015). doi: 10.1038/srep11541.
21. Roger S., et al. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. Int. J. Biochem. Cell Biol. 39, 774-786 (2007). doi: 10.1016/j.biocel.2006.12.007.
22. Novella S. P., Hisama, F. M., Dib-Hajj, S. D., & Waxman, S. G. A case of inherited erythromelalgia. Na.t Clin. Pract. Neurol. 3, 229-34. (2007). doi: 10.1038/ncpneuro0425.
23. Fertleman, C.R., et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52, 767-774(2006). doi: 10.1016/j.neuron.2006.10.006.
24. Drenth, J. P. & Waxman, S. G. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J. Clin. Invest. 117, 3603-3609 (2007). doi: 10.1172/JCI33297.
25. Paul, D., Soignier, R. D., Minor, L, Tau, H, Songu-Mize, E. & Gould, H. J., III. Regulation and pharmacological blockade of sodium-potassium ATPase: a novel pathway to neuropathy. J. Neurol. Sci. 340, 139-43 (2014). doi: 10.1016/j.jns.2014.03.012.
26. Songu-Mize, E., Liu, X. & Hymel, L. Effect of mechanical strain on expression of Na+,K+-ATPase alpha subunits in rat aortic smooth muscle cells. Am. J. Med. Sci. 316, 196-199 1998. doi: 10.1097/00000441-199809000-00008.
27. Casey, G.P., Paul, D., & Gould, H. J. III. Insulin is essential for the recovery from allodynia induced by complete Freund’s adjuvant. Pain Medicine 11, 1401-1410 (2010). DOI: 10.1111/j.1526-4637.2010.00936.x.
28. Brackenbury. Voltage-gated sodium channels and metastatic disease. Channels 6, 352-361 (2012). doi: 10.4161/chan.21910.
29. Onkal, R., & Djamgoz, M. B. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. Eur. J. Pharmacol. 625, 206-219 (2009). doi: 10.1016/j.ejphar.2009.08.040.
30. Leslie T. K. et al. Sodium homeostasis in the tumour microenvironment. Biochim. Biophys. Acta Rev. Cancer 1872, 188304 (2019). doi: 10.1016/j.bbcan.2019.07.001.
31. Durlacher, C. T. et al., Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment. Clin. Exp. Pharmacol. Physiol.42, 427-443 (2015). doi: 10.1111/1440-1681.12385.